CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2014
Filed with the SEC on Aug 5, 2014 and accepted by EDGAR at Aug 5, 2014, 16:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-04-01 to 2014-06-30 | $34.60bn | us-gaap:Revenues |
| Revenue | 6 months2014-01-01 to 2014-06-30 | $67.29bn | us-gaap:Revenues |
| Cost of revenue | 3 months2014-04-01 to 2014-06-30 | $28.28bn | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2014-01-01 to 2014-06-30 | $55.02bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-04-01 to 2014-06-30 | $6.32bn | us-gaap:GrossProfit |
| Gross profit | 6 months2014-01-01 to 2014-06-30 | $12.27bn | us-gaap:GrossProfit |
| Operating income | 3 months2014-04-01 to 2014-06-30 | $2.21bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2014-01-01 to 2014-06-30 | $4.23bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-04-01 to 2014-06-30 | $161.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2014-01-01 to 2014-06-30 | $322.0m | us-gaap:InterestExpense |
| Income tax | 3 months2014-04-01 to 2014-06-30 | $804.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2014-01-01 to 2014-06-30 | $1.54bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-04-01 to 2014-06-30 | $1.25bn | us-gaap:ProfitLoss |
| Net income | 6 months2014-01-01 to 2014-06-30 | $2.38bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2014-04-01 to 2014-06-30 | $1.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2014-01-01 to 2014-06-30 | $2.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-04-01 to 2014-06-30 | $1.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2014-01-01 to 2014-06-30 | $2.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-04-01 to 2014-06-30 | 1,174,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2014-01-01 to 2014-06-30 | 1,182,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2014-01-01 to 2014-06-30 | $3.07bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2014-01-01 to 2014-06-30 | $891.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2014-01-01 to 2014-06-30 | $647.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2014-01-01 to 2014-06-30 | $2.00bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-06-30 | $1.61bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-06-30 | $24.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-06-30 | $72.59bn | us-gaap:Assets |
| Current liabilities | At period end2014-06-30 | $16.63bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-06-30 | $38.13bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000064803-14-000028. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.